301263.SZ
Guangdong Taienkang Pharmaceutical Co., Ltd.
SZSE · F 批发零售 · CN
CNY 18.35
−3.57%Sep 7, 2026, 12:13 UTC
Taienkang's controlled subsidiary Jiangsu Bochuangyuan Biomedical Technology Co., Ltd. completed enrollment of the first subject in the Phase IIb clinical trial of CKBA cream for the treatment of rosacea.
Source:Aug 20, 2026, 10:51 UTC
Taienkang's wholly-owned subsidiary Shandong Huabo Kaisheng Biotechnology Co., Ltd. received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration for cisplatin polymer micelles for injection.
Source:Aug 7, 2026, 09:38 UTC
Tai Enkang's wholly-owned subsidiary Huabo Kaisheng won the bid for baricitinib tablets (2mg*28 tablets/box) in the 12th national centralized drug procurement.
Source: